Podcasts

Adam D. Cohen, MD, Discusses Therapy Options for Multiple Myeloma

Image removed.

 

Adam D. Cohen, MD, Director, Myeloma Immunotherapy, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, shares his thoughts on several abstracts presented at the 2018 ASH Annual Meeting that pertained to therapy options for multiple myeloma.

Listen to the entire 3-part podcast series below.

---

Earlier Daratumamab Use Feasible for Relapsed/ Refractory Multiple Myeloma

Dr Cohen shares data from several studies that explored  the use of daratumamab earlier in multiple myeloma treatment.

Listen Here

 

Novel Immunotherapy Approaches for Multiple Myeloma

Dr Cohen discusses a few promising immunotherapy approaches for patients with multiple myeloma.

Listen Here

 

Ixazomib Promising Maintenance Therapy Option for Multiple Myeloma

Dr Cohen shares data from a study looking at ixazomib as a maintenance therapy option for patients with multiple myeloma.

Listen Here

 

 

Stay in the know.
OncNet Newsletter